MElanoma Research Lymph Node Prediction Implementation National_001

Sentinel Node With Ultrasound Contrast in Melanoma

NCT00370136 ·Status: COMPLETED ·Phase: NA

Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma

NCT00386906 ·Status: COMPLETED ·Phase: PHASE1

Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment

NCT02105168 ·Status: UNKNOWN ·Phase: NA

Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma

NCT00450593 ·Status: UNKNOWN

Peripheral Blood and/or Bone Marrow, Including Detection of Occult Metastases, in Patients With Melanoma

NCT00588198 ·Status: COMPLETED

Morphological, Genetic and Tumour Microenvironment Characterisation in Uveal Melanoma

NCT05889481 ·Status: UNKNOWN

Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma

NCT00685750 ·Status: TERMINATED ·Phase: NA

Perioperative Examination of Inflammatory Markers in Relation to Sentinel Lymph Node Biopsy in Patients With Melanoma; a Pilot Study

NCT05817149 ·Status: COMPLETED

A Model for Genetic Susceptibility: Melanoma

NCT00591500 ·Status: ACTIVE_NOT_RECRUITING

Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile

NCT01454297 ·Status: COMPLETED

Assessment of Circulating Tumor Cells and microRNAs in Patients With Metastatic Non-cutaneous Melanoma

NCT06863870 ·Status: ACTIVE_NOT_RECRUITING

Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer

NCT05758948 ·Status: UNKNOWN

The Study Aims to Measure the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography and to Analyse Differences Depending on the Course of the Disease.

NCT06765850 ·Status: RECRUITING

Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment

NCT01205815 ·Status: RECRUITING

Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate

NCT01209299 ·Status: COMPLETED

Understanding the Transition from Normal Melanocytes to Nevus to Melanoma

NCT06605417 ·Status: RECRUITING

Differential Risks for Melanoma: p16 and DNA Repair

NCT00615095 ·Status: COMPLETED

A Prospective Natural History Study in Uveal Melanoma

NCT04588662 ·Status: ACTIVE_NOT_RECRUITING

Metabolic Phenotypes in Melanoma

NCT05570227 ·Status: RECRUITING ·Phase: NA

Predicting Progression of Developing Myeloma in a High-Risk Screened Population and General Population

NCT05837884 ·Status: RECRUITING

Circulating Blood Profile to Predict Recurrence and Response to Systemic Therapy

NCT03267381 ·Status: COMPLETED

Melanoma: Genomic Profiles, Molecular Markers and Therapeutic Implications

NCT05119829 ·Status: UNKNOWN

Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma

NCT00991991 ·Status: TERMINATED

Five Year Study to Track Use of DecisionDX-Melanoma Test in Patients With Cutaneous Melanoma and Associated Patient Outcomes

NCT02355587 ·Status: TERMINATED

Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck

NCT05108090 ·Status: RECRUITING ·Phase: NA